Metabolomic profiling of biomarkers of liver X receptor-induced toxicity in mouse liver tissue

Metabolomics

Volumn 7, Issue 1, 2011, Pages 54-70

  MacIntyre, Lynsey ^a   Zheng, Liang ^a   Scullion, Paul ^b   Keating, Pat ^a   Watson, David G ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b Research Laboratories   (United Kingdom)

Author keywords

Carnitines; Fourier transform MS; Liver X receptor; Toxicity; Triacylglycerols

Indexed keywords

BIOLOGICAL MARKER; CARNITINE DERIVATIVE; HYDROXYMETHYLGLUTARYL CARNITINE; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; METHYLGLUTARYL CARNITINE; OLEIC ACID; PHOSPHATIDYLCHOLINE; SODIUM CHLORIDE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GAS CHROMATOGRAPHY; HYDROPHILIC INTERACTION CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; LIVER METABOLISM; LIVER TOXICITY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; MOUSE; NONHUMAN;

ANIMALIA; MUS;

EID: 79951722220     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-010-0235-6     Document Type: Article

References (112)

1. Altmaier, E., Ramsay, S. L., Graber, A., Mewes, H. W., Weinberger, K. M., & Suhre, K. (2008). Bioinformatics analysis of targeted metabolomics-Uncovering old and new tales of diabetic mice under medication. Endocrinology, 149, 3478-3489.
2. Anthonisen, E. H., Berven, L., Holm, S., Nygard, M., Nebb, H. I., & Gronning-Wang, L. M. (2010). Nuclear receptor liver X receptor is O-GlcNAc-modified in response to glucose. Journal of Biological Chemistry, 285, 1607-1615.
3. Bajad, S. U., Lu, W., Kimball, E. H., Yuan, J., Peterson, C., & Rabinowitz, J. D. (2006). Separation and quantitation of water soluble cellular metabolites by hydrophilic interaction chromatography-tandem mass spectrometry. Journal of Chromatography. A, 1125, 76-88.
4. Bao, Y., Zhao, T., Wang, X., Qiu, Y., Su, M., & Jia, W. (2009). Metabonomic variations in the drug-treated type 2 diabetes mellitus patients and healthy volunteers. Journal of Proteome Research, 8, 1623-1630.
5. Beger, R. D., Hansen, D. K., Schnackenberg, L. K., Cross, B. M., Fatollahi, J. J., Lagunero, F. T., et al. (2009). Single valproic acid treatment inhibits glycogen and RNA ribose turnover while disrupting glucose-derived cholesterol synthesis in liver as revealed by the [U-C(6)]-d-glucose tracer in mice. Metabolomics, 5, 336-345.
6. Beger, R. D., Sun, J., & Schnackenberg, L. K. (2010). Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicology and Applied Pharmacology, 243, 154-166.
7. Benabdellah, F., Touboul, D., Brunelle, A., & Laprevote, O. (2009). In situ primary metabolites localization on a rat brain section by chemical mass spectrometry imaging. Analytical Chemistry, 81, 5557-5560.
8. Bollard, M. E., Contel, N. R., Ebbels, T. M., Smith, L., Beckonert, O., Cantor, G. H., et al. (2010). NMR-based metabolic profiling identifies biomarkers of liver regeneration following partial hepatectomy in the rat. Journal of Proteome Research, 9, 59-69.
9. Calvano, C. D., Zambonin, C. G., & Jensen, O. N. (2008). Assessment of lectin and HILIC based enrichment protocols for characterization of serum glycoproteins by mass spectrometry. Journal of Proteomics, 71, 304-317.
10. Cha, J. Y., & Repa, J. J. (2007). The liver X receptor (LXR) and hepatic lipogenesis. The carbohydrate-response element-binding protein is a target gene of LXR. Journal of Biological Chemistry, 282, 743-751.
11. Chen, C., Krausz, K. W., Shah, Y. M., Idle, J. R., & Gonzalez, F. J. (2009). Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chemical Research in Toxicology, 22, 699-707.
12. Christie, W. W. (2003). Lipid analysis: Isolation, separation. Identification & structural analysis of lipids. Bridgwater, UK: The Oily Press.
13. 31P statistical total correlation NMR spectroscopy of intact liver for metabolic biomarker assignment: Application to galactosamine-induced hepatotoxicity. Analytical Chemistry, 79, 8956-8966.
14. Coen, M., Lenz, E. M., Nicholson, J. K., Wilson, I. D., Pognan, F., & Lindon, J. C. (2003). An integrated metabonomic investigation of acetaminophen toxicity in the mouse using NMR spectroscopy. Chemical Research in Toxicology, 16, 295-303.
15. 1H magic-angle-spinning NMR spectroscopy: Interaction between p-Xylene and C18-bonded silica. Analytical Chemistry, 76, 3023-3028.
16. 1H NMR: Application in metabonomic toxicology studies. Analytical Chemistry, 77, 4556-4562.
17. Cubbon, S., Bradbury, T., Wilson, J., & Thomas-Oates, J. (2007). Hydrophilic interaction chromatography for mass spectrometric metabonomic studies of urine. Analytical Chemistry, 79, 8911-8918.
18. Dettmer, K., Aronov, P. A., & Hammock, B. D. (2007). Mass spectrometry-based metabolomics. Mass Spectrometry Reviews, 26, 51-78.
19. 13C HMBC-NMR spectroscopy combined with pattern recognition procedures performed on filtered variables. Analytical Chemistry, 74, 2261-2273.
20. Dunn, W. B., Bailey, N. J., & Johnson, H. E. (2005). Measuring the metabolome: Current analytical technologies. Analyst, 130, 606-625.
21. Dunn, W. B., & Ellis, D. I. (2005). Metabolomics: Current analytical platforms and methodologies. TrAC Trends in Analytical Chemistry, 24, 285-294.
22. Ebbels, T. M., Keun, H. C., Beckonert, O. P., Bollard, M. E., Lindon, J. C., Holmes, E., et al. (2007). Prediction and classification of drug toxicity using probabilistic modeling of temporal metabolic data: The consortium on metabonomic toxicology screening approach. Journal of Proteome Research, 6, 4407-4422.
23. Edwards, J. L., & Kennedy, R. T. (2005). Metabolomic analysis of eukaryotic tissue and prokaryotes using negative mode MALDI time-of-flight mass spectrometry. Analytical Chemistry, 77, 2201-2209.
24. Eiris, J., Ribes, A., Fernandez-Prieto, R., Rodriguez-Garcia, J., Rodriguez-Segade, S., & Castro-Gago, M. (1998). 3-hydroxy-3-methylglutaric aciduria and recurrent Reye-like syndrome. Revista de neurologia, 26, 911-914.
25. Fahy, E., Subramaniam, S., Brown, H. A., Glass, C. K., Merrill, A. H., Jr., Murphy, R. C., et al. (2005). A comprehensive classification system for lipids. Journal of Lipid Research, 46, 839-861.
26. Ferrara, C. T., Wang, P., Neto, E. C., Stevens, R. D., Bain, J. R., Wenner, B. R., et al. (2008). Genetic networks of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet, 4, e1000034.
27. Fievet, C., & Staels, B. (2009). Liver X receptor modulators: Effects on lipid metabolism and potential use in the treatment of atherosclerosis. Biochemical Pharmacology, 77, 1316-1327.
28. Garrod, S., Bollard, M. E., Nicholls, A. W., Connor, S. C., Connelly, J., Nicholson, J. K., et al. (2005). Integrated metabonomic analysis of the multiorgan effects of hydrazine toxicity in the rat. Chemical Research in Toxicology, 18, 115-122.
29. Gika, H. G., Theodoridis, G. A., & Wilson, I. D. (2008). Hydrophilic interaction and reversed-phase ultra-performance liquid chromatography TOF-MS for metabonomic analysis of Zucker rat urine. Journal of Separation Science, 31, 1598-1608.
30. Grefhorst, A., Elzinga, B. M., Voshol, P. J., Plosch, T., Kok, T., Bloks, V. W., et al. (2002). Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles. Journal of Biological Chemistry, 277, 34182-34190.
31. Griffin, J. L. (2003). Metabonomics: NMR spectroscopy and pattern recognition analysis of body fluids and tissues for characterisation of xenobiotic toxicity and disease diagnosis. Current Opinion in Chemical Biology, 7, 648-654.
32. 1H NMR spectroscopy and reverse transcription-PCR analysis of apoptosis in a rat glioma. Analytical Chemistry, 78, 1546-1552.
33. Griffin, J. L., & Bollard, M. E. (2004). Metabonomics: Its potential as a tool in toxicology for safety assessment and data integration. Current Drug Metabolism, 5, 389-398.
34. 1H NMR spectroscopy. Biochimica et Biophysica Acta, 1619, 151-158.
35. Hegardt, F. G. (1999). Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: A control enzyme in ketogenesis. Biochemical Journal, 338(Pt 3), 569-582.
36. Heijne, W. H., Lamers, R. J., van Bladeren, P. J., Groten, J. P., van Nesselrooij, J. H., & van Ommen, B. (2005). Profiles of metabolites and gene expression in rats with chemically induced hepatic necrosis. Toxicologic Pathology, 33, 425-433.
37. Holmes, E., Bonner, F. W., Sweatman, B. C., Lindon, J. C., Beddell, C. R., Rahr, E., et al. (1992). Nuclear-magnetic-resonance spectroscopy and pattern-recognition analysis of the biochemical processes associated with the progression of and recovery from nephrotoxic lesions in the rat induced by Mercury(Ii) Chloride and 2-Bromoethanamine. Molecular Pharmacology, 42, 922-930.
38. Holmes, E., Tsang, T. M., & Tabrizi, S. J. (2006). The application of NMR-based metabonomics in neurological disorders. NeuroRx, 3, 358-372.
39. 1H MAS NMR liver tissue spectra exemplified using a study of glycine protection of galactosamine toxicity. Magnetic Resonance in Chemistry, 47(1), S47-S53.
40. Hu, Q., Noll, R. J., Li, H., Makarov, A., Hardman, M., & Graham Cooks, R. (2005). The Orbitrap: A new mass spectrometer. Journal of Mass Spectrometry and Ion Physics, 40, 430-443.
41. Idborg, H., Zamani, L., Edlund, P. O., Schuppe-Koistinen, I., & Jacobsson, S. P. (2005). Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 828, 14-20.
42. Idborg-Bjorkman, H., Edlund, P. O., Kvalheim, O. M., Schuppe-Koistinen, I., & Jacobsson, S. P. (2003). Screening of biomarkers in rat urine using LC/electrospray ionization-MS and two-way data analysis. Analytical Chemistry, 75, 4784-4792.
43. Ishihara, K., Katsutani, N., & Aoki, T. (2006). A metabonomics study of the hepatotoxicants galactosamine, methylene dianiline and clofibrate in rats. Basic & Clinical Pharmacology & Toxicology, 99, 251-260.
44. Kamleh, A., Barrett, M. P., Wildridge, D., Burchmore, R. J., Scheltema, R. A., & Watson, D. G. (2008a). Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: A method with wide applicability to analysis of biomolecules. Rapid Communications in Mass Spectrometry, 22, 1912-1918.
45. Kamleh, M. A., Dow, J. A., & Watson, D. G. (2009a). Applications of mass spectrometry in metabolomic studies of animal model and invertebrate systems. Briefings in Functional Genomics & Proteomics, 8, 28-48.
46. Kamleh, M. A., Hobani, Y., Dow, J. A., & Watson, D. G. (2008b). Metabolomic profiling of Drosophila using liquid chromatography Fourier transform mass spectrometry. FEBS Letters, 582, 2916-2922.
47. Kamleh, M. A., Hobani, Y., Dow, J. A., Zheng, L., & Watson, D. G. (2009b). Towards a platform for the metabonomic profiling of different strains of Drosophila melanogaster using liquid chromatography-Fourier transform mass spectrometry. FEBS Journal, 276, 6798-6809.
48. Keun, H. C., Ebbels, T. M., Antti, H., Bollard, M. E., Beckonert, O., Schlotterbeck, G., et al. (2002). Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chemical Research in Toxicology, 15, 1380-1386.
49. Kind, T., Tolstikov, V., Fiehn, O., & Weiss, R. H. (2007). A comprehensive urinary metabolomic approach for identifying kidney cancerr. Analytical Biochemistry, 363, 185-195.
50. Lafaye, A., Junot, C., Pereira, Y., Lagniel, G., Tabet, J. C., Ezan, E., et al. (2005a). Combined proteome and metabolite-profiling analyses reveal surprising insights into yeast sulfur metabolism. Journal of Biological Chemistry, 280, 24723-24730.
51. Lafaye, A., Junot, C., Ramounet-Le Gall, B., Fritsch, P., Tabet, J. C., & Ezan, E. (2003). Metabolite profiling in rat urine by liquid chromatography/electrospray ion trap mass spectrometry. Application to the study of heavy metal toxicity. Rapid Communications in Mass Spectrometry, 17, 2541-2549.
52. Lafaye, A., Labarre, J., Tabet, J. C., Ezan, E., & Junot, C. (2005b). Liquid chromatography-mass spectrometry and 15 N metabolic labeling for quantitative metabolic profiling. Analytical Chemistry, 77, 2026-2033.
53. Lay, J. O., Jr., Liyanage, R., Durham, B., & Brooks, J. (2006). Rapid characterization of edible oils by direct matrix-assisted laser desorption/ionization time-of-flight mass spectrometry analysis using triacylglycerols. Rapid Communications in Mass Spectrometry, 20, 952-958.
54. 1H NMR spectroscopy, HPLC-TOF/MS and chemometrics. Journal of Pharmaceutical and Biomedical Analysis, 35, 599-608.
55. 1H NMR and HPLC-TOF/MS: Time dependent changes in the urinary profile of endogenous metabolites as a result of nephrotoxicity. Analyst, 129, 535-541.
56. Lenz, E. M., & Wilson, I. D. (2007). Analytical strategies in metabonomics. Journal of Proteome Research, 6, 443-458.
57. 13C NMR spectra. Analytical Chemistry, 79, 9385-9390.
58. Lindon, J. C., Holmes, E., Bollard, M. E., Stanley, E. G., & Nicholson, J. K. (2004). Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers, 9, 1-31.
59. Lindon, J. C., Holmes, E., & Nicholson, J. K. (2007). Metabonomics in pharmaceutical R& D. FEBS Journal, 274, 1140-1151.
60. Lindon, J. C., Keun, H. C., Ebbels, T. M., Pearce, J. M., Holmes, E., & Nicholson, J. K. (2005a). The Consortium for Metabonomic Toxicology (COMET): Aims, activities and achievements. Pharmacogenomics, 6, 691-699.
61. Lindon, J. C., Nicholson, J. K., Holmes, E., Antti, H., Bollard, M. E., Keun, H., et al. (2003). Contemporary issues in toxicology the role of metabonomics in toxicology and its evaluation by the COMET project. Toxicology and Applied Pharmacology, 187, 137-146.
62. Lindon, J. C., Nicholson, J. K., Holmes, E., Keun, H. C., Craig, A., Pearce, J. T., et al. (2005b). Summary recommendations for standardization and reporting of metabolic analyses. Nature Biotechnology, 23, 833-838.
63. Mortishire-Smith, R. J., Skiles, G. L., Lawrence, J. W., Spence, S., Nicholls, A. W., Johnson, B. A., et al. (2004). Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chemical Research in Toxicology, 17, 165-173.
64. Nicholson, J. K., Connelly, J., Lindon, J. C., & Holmes, E. (2002). Metabonomics: A platform for studying drug toxicity and gene function. Nature Reviews. Drug Discovery, 1, 153-161.
65. Nicholson, J., Keun, H., & Ebbels, T. (2007). COMET and the challenge of drug safety screening. Journal of Proteome Research, 6, 4098-4099.
66. Nordstrom, A., Want, E., Northen, T., Lehtio, J., & Siuzdak, G. (2008). Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics. Analytical Chemistry, 80, 421-429.
67. Ohta, D., Kanaya, S., & Suzuki, H. (2010). Application of Fourier-transform ion cyclotron resonance mass spectrometry to metabolic profiling and metabolite identification. Current Opinion in Biotechnology, 21, 35-44.
68. Paek, I. B., Moon, Y., Ji, H. Y., Kim, H. H., Lee, H. W., Lee, Y. B., et al. (2004). Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levosulpiride in human plasma. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 809, 345-350.
69. Pasikanti, K. K., Ho, P. C., & Chan, E. C. (2008a). Gas chromatography/mass spectrometry in metabolic profiling of biological fluids. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 871, 202-211.
70. Pasikanti, K. K., Ho, P. C., & Chan, E. C. (2008b). Development and validation of a gas chromatography/mass spectrometry metabonomic platform for the global profiling of urinary metabolites. Rapid Communications in Mass Spectrometry, 22, 2984-2992.
71. Picariello, G., Paduano, A., Sacchi, R., & Addeo, F. (2009). Maldi-tof mass spectrometry profiling of polar and nonpolar fractions in heated vegetable oils. Journal of Agriculture and Food Chemistry, 57, 5391-5400.
72. Plumb, R. S., Granger, J. H., Stumpf, C. L., Johnson, K. A., Smith, B. W., Gaulitz, S., et al. (2005). A rapid screening approach to metabonomics using UPLC and oa-TOF mass spectrometry: Application to age, gender and diurnal variation in normal/Zucker obese rats and black, white and nude mice. Analyst, 130, 844-849.
73. Plumb, R., Granger, J., Stumpf, C., Wilson, I. D., Evans, J. A., & Lenz, E. M. (2003). Metabonomic analysis of mouse urine by liquid-chromatography-time of flight mass spectrometry (LC-TOFMS): Detection of strain, diurnal and gender differences. Analyst, 128, 819-823.
74. Plumb, R. S., Johnson, K. A., Rainville, P., Shockcor, J. P., Williams, R., Granger, J. H., et al. (2006). The detection of phenotypic differences in the metabolic plasma profile of three strains of Zucker rats at 20 weeks of age using ultra-performance liquid chromatography/orthogonal acceleration time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry, 20, 2800-2806.
75. Plumb, R. S., Jones, M. D., Rainville, P. D., & Nicholson, J. K. (2008). A rapid simple approach to screening pharmaceutical products using ultra-performance LC coupled to time-of-flight mass spectrometry and pattern recognition. Journal of Chromatographic Science, 46, 193-198.
76. Plumb, R. S., Rainville, P. D., Potts, W. B., III, Johnson, K. A., Gika, E., & Wilson, I. D. (2009). Application of ultra performance liquid chromatography-mass spectrometry to profiling rat and dog bile. Journal of Proteome Research, 8, 2495-2500.
77. Plumb, R. S., Stumpf, C. L., Gorenstein, M. V., Castro-Perez, J. M., Dear, G. J., Anthony, M., et al. (2002). Metabonomics: The use of electrospray mass spectrometry coupled to reversed-phase liquid chromatography shows potential for the screening of rat urine in drug development. Rapid Communications in Mass Spectrometry, 16, 1991-1996.
78. Portilla, D., Li, S., Nagothu, K. K., Megyesi, J., Kaissling, B., Schnackenberg, L., et al. (2006). Metabolomic study of cisplatin-induced nephrotoxicity. Kidney International, 69, 2194-2204.
79. Ramautar, R., Ratnayake, C. K., Somsen, G. W., & de Jong, G. J. (2009). Capillary electrophoresis-mass spectrometry using an in-line sol-gel concentrator for the determination of methionine enkephalin in cerebrospinal fluid. Talanta, 78, 638-642.
80. Reo, N. V. (2002). NMR-based metabolomics. Drug and Chemical Toxicology, 25, 375-382.
81. Robertson, D. G. (2005). Metabonomics in toxicology: A review. Toxicological Sciences, 85, 809-822.
82. Robertson, D. G., Reily, M. D., & Baker, J. D. (2005). Metabonomics in preclinical drug development. Expert Opinion on Drug Metabolism & Toxicology, 1, 363-376.
83. Robertson, D. G., Reily, M. D., Sigler, R. E., Wells, D. F., Paterson, D. A., & Braden, T. K. (2000). Metabonomics: Evaluation of nuclear magnetic resonance (NMR) and pattern recognition technology for rapid in vivo screening of liver and kidney toxicants. Toxicological Sciences, 57, 326-337.
84. Roe, C. R., Millington, D. S., Maltby, D. A., & Kinnebrew, P. (1986). Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reye-like syndromes. Journal of Pediatrics, 108, 13-18.
85. Schindhelm, R. K., Diamant, M., Dekker, J. M., Tushuizen, M. E., Teerlink, T., & Heine, R. J. (2006). Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes/Metabolism Research and Reviews, 22, 437-443.
86. Schnackenberg, L. K. (2007). Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Review of Molecular Diagnostics, 7, 247-259.
87. Schnackenberg, L. K., Jones, R. C., Thyparambil, S., Taylor, J. T., Han, T., Tong, W., et al. (2006). An integrated study of acute effects of valproic acid in the liver using metabonomics, proteomics, and transcriptomics platforms. OMICS, 10, 1-14.
88. Schnackenberg, L. K., Sun, J., Espandiari, P., Holland, R. D., Hanig, J., & Beger, R. D. (2007). Metabonomics evaluations of age-related changes in the urinary compositions of male Sprague Dawley rats and effects of data normalization methods on statistical and quantitative analysis. BMC Bioinformatics, 8(7), S3.
89. Schultz, J. R., Tu, H., Luk, A., Repa, J. J., Medina, J. C., Li, L., et al. (2000). Role of LXRs in control of lipogenesis. Genes and Development, 14, 2831-2838.
90. Shi, C., Wu, C. Q., Cao, A. M., Sheng, H. Z., Yan, X. Z., & Liao, M. Y. (2007). NMR-spectroscopy-based metabonomic approach to the analysis of Bay41-4109, a novel anti-HBV compound, induced hepatotoxicity in rats. Toxicology Letters, 173, 161-167.
91. Smilde, A. K., van der Werf, M. J., Bijlsma, S., der Vat, B. J., & Jellema, R. H. (2005). Fusion of mass spectrometry-based metabolomics data. Analytical Chemistry, 77, 6729-6736.
92. Spagou, K., Tsoukali, H., Raikos, N., Gika, H., Wilson, I. D., & Theodoridis, G. (2010). Hydrophilic interaction chromatography coupled to MS for metabonomic/metabolomic studies. Journal of Separation Science, 33, 716-727.
93. Sun, J., Schnackenberg, L. K., Holland, R. D., Schmitt, T. C., Cantor, G. H., Dragan, Y. P., et al. (2008). Metabonomics evaluation of urine from rats given acute and chronic doses of acetaminophen using NMR and UPLC/MS. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 871, 328-340.
94. Sun, J., Von Tungeln, L. S., Hines, W., & Beger, R. D. (2009). Identification of metabolite profiles of the catechol-O-methyl transferase inhibitor tolcapone in rat urine using LC/MS-based metabonomics analysis. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 877, 2557-2565.
95. Sun, G., Yang, K., Zhao, Z. D., Guan, S. P., Han, X. L., & Gross, R. W. (2007). Shotgun metabolomics approach for the analysis of negatively charged water-soluble cellular metabolites from mouse heart tissue. Analytical Chemistry, 79, 6629-6640.
96. Tang, H., Wang, Y., Nicholson, J. K., & Lindon, J. C. (2004). Use of relaxation-edited one-dimensional and two dimensional nuclear magnetic resonance spectroscopy to improve detection of small metabolites in blood plasma. Analytical Biochemistry, 325, 260-272.
97. Theodoridis, G., Gika, H. G., & Wilson, I. D. (2008). LC-MS-based methodology for global metabolite profiling in metabonomics/metabolomics. TrAC Trends in Analytical Chemistry, 27, 251-260.
98. Ulven, S. M., Dalen, K. T., Gustafsson, J. A., & Nebb, H. I. (2005). LXR is crucial in lipid metabolism. Prostaglandins Leukotrienes and Essential Fatty Acids, 73, 59-63.
99. van der Werf, M. J., Overkamp, K. M., Muilwijk, B., Coulier, L., & Hankemeier, T. (2007). Microbial metabolomics: Toward a platform with full metabolome coverage. Analytical Biochemistry, 370, 17-25.
100. Wang, J., Einarsson, C., Murphy, C., Parini, P., Bjorkhem, I., Gafvels, M., et al. (2006a). Studies on LXR- and FXR-mediated effects on cholesterol homeostasis in normal and cholic acid-depleted mice. Journal of Lipid Research, 47, 421-430.
101. Wang, N., Ranalletta, M., Matsuura, F., Peng, F., & Tall, A. R. (2006b). LXR-induced redistribution of ABCG1 to plasma membrane in macrophages enhances cholesterol mass efflux to HDL. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 1310-1316.
102. Wang, J., Reijmers, T., Chen, L., van Der Heijden, R., Wang, M., Peng, S., et al. (2009). Systems toxicology study of doxorubicin on rats using ultra performance liquid chromatography coupled with mass spectrometry based metabolomics. Metabolomics, 5, 407-418.
103. Watson, D. G. (1994). TITLE. In P. Baugh (Ed.), Gas chromatography: A practical approach (pp. 133-169). Oxford: IRL Press.
104. Williams, R. E., Lenz, E. M., Evans, J. A., Wilson, I. D., Granger, J. H., Plumb, R. S., et al. (2005a). A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. Journal of Pharmaceutical and Biomedical Analysis, 38, 465-471.
105. 1H NMR and HPLC-TOF MS. Molecular bioSystems, 1, 166-175.
106. Wilson, I. D., Plumb, R., Granger, J., Major, H., Williams, R., & Lenz, E. M. (2005). HPLC-MS-based methods for the study of metabonomics. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817, 67-76.
107. Wu, H., Southam, A. D., Hines, A., & Viant, M. R. (2008). High-throughput tissue extraction protocol for NMR- and MS-based metabolomics. Analytical Biochemistry, 372, 204-212.
108. Yang, J., Song, S. L., Castro-Perez, J., Plumb, R. S., & Xu, G. W. (2005). Metabonomics and its applications. Sheng Wu Gong Cheng Xue Bao, 21, 1-5.
109. Zammit, V. A., Ramsay, R. R., Bonomini, M., & Arduini, A. (2009). Carntine, mitochondrial function and therapy. Advanced Drug Delivery Reviews, 61, 1353-1362.
110. Zhang, X., Rauch, A., Lee, H., Xiao, H., Rainer, G., & Logothetis, N. K. (2007). Capillary hydrophilic interaction chromatography/mass spectrometry for simultaneous determination of multiple neurotransmitters in primate cerebral cortex. Rapid Communications in Mass Spectrometry, 21, 3621-3628.
111. Zhang, Y., Repa, J. J., Inoue, Y., Hayhurst, G. P., Gonzalez, F. J., & Mangelsdorf, D. J. (2004). Identification of a liver-specific uridine phosphorylase that is regulated by multiple lipid-sensing nuclear receptors. Molecular Endocrinology, 18, 851-862.
112. Zheng, L., T'Kind, R., Decuypere, S., von Freyend, S. J., Coombs, G. H., & Watson, D. G. (2010). Profiling of lipids in Leishmania donovani using hydrophilic interaction chromatography in combination with Fourier transform mass spectrometry. Rapid Communications in Mass Spectrometry, 24, 2074-2082.